RESUMEN
This study was performed to evaluate the utilization and outcomes of palivizumab in high risk children born prematurely with chronic lung disease (CLD). A retrospective review of 128 patients was conducted from September 2004 to March 2009 at the Ajou University Hospital. All patients were diagnosed with CLD, were born at Asunto(s)
Anticuerpos Monoclonales/uso terapéutico
, Antivirales/uso terapéutico
, Displasia Broncopulmonar/complicaciones
, Infecciones por Virus Sincitial Respiratorio/prevención & control
, Anticuerpos Monoclonales Humanizados
, Displasia Broncopulmonar/diagnóstico
, Demografía
, Hospitalización
, Humanos
, Lactante
, Recién Nacido
, Palivizumab
, Nacimiento Prematuro
, República de Corea
, Infecciones por Virus Sincitial Respiratorio/complicaciones
, Estudios Retrospectivos
, Factores de Riesgo
, Resultado del Tratamiento
RESUMEN
Insulin contains two inter-chain disulfide bonds between the A and B chains (A7-B7 and A20-B19), and one intra-chain linkage in the A chain (A6-A11). To investigate the role of each disulfide bond in the structure, function and stability of the molecule, three des mutants of human insulin, each lacking one of the three disulfide bonds, were prepared by enzymatic conversion of refolded mini-proinsulins. Structural and biological studies of the three des mutants revealed that all three disulfide bonds are essential for the receptor binding activity of insulin, whereas the different disulfide bonds make different contributions to the overall structure of insulin. Deletion of the A20-B19 disulfide bond had the most substantial influence on the structure as indicated by loss of ordered secondary structure, increased susceptibility to proteolysis, and markedly reduced compactness. Deletion of the A6-A11 disulfide bond caused the least perturbation to the structure. In addition, different refolding efficiencies between the three des mutants suggest that the disulfide bonds are formed sequentially in the order A20-B19, A7-B7 and A6-A11 in the folding pathway of proinsulin.